.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Johnson and Johnson
Farmers Insurance
McKesson
McKinsey
Baxter
US Department of Justice
Cantor Fitzgerald
Healthtrust

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,962,128

« Back to Dashboard

Summary for Patent: 4,962,128

Title: Method of treating anxiety-related disorders using sertraline
Abstract:A method of treating anxiety-related disorders comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in preventing or alleviating anxiety and the symptoms associated with anxiety-related disorders.
Inventor(s): Doogan; Declan P. (Canterbury, GB2), Scappaticci; Karen A. (New York, NY), Hackett; Elizabeth (New York, NY)
Assignee: Pfizer Inc. (New York, NY)
Application Number:07/431,000
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 4,962,128

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria212223► Subscribe
Austria269068► Subscribe
Austria327743► Subscribe
Australia616127► Subscribe
Australia6571590► Subscribe
Canada2029065► Subscribe
Germany69033903► Subscribe
Germany69034149► Subscribe
Germany69034223► Subscribe
Denmark0429189► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Express Scripts
Argus Health
Moodys
McKesson
McKinsey
Colorcon
Chubb
UBS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot